Follicum AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Subsidiary
- Established
- 2004-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.follicum.com
Clinical Trials
5
Active:2
Completed:3
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers
Phase 2
Completed
- Conditions
- Androgenetic Alopecia
- Interventions
- Drug: Topical formulation
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2021-03-01
- Lead Sponsor
- Follicum AB
- Target Recruit Count
- 209
- Registration Number
- NCT04774874
- Locations
- 🇩🇪
ProDerm GmbH, Hamburg, Germany
To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Follicum AB
- Target Recruit Count
- 60
- Registration Number
- NCT03467412
- Locations
- 🇩🇪
Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin, Berlin, Germany
🇩🇪Bioskin GmbH, Hamburg, Germany
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
- First Posted Date
- 2016-06-08
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- Follicum AB
- Target Recruit Count
- 44
- Registration Number
- NCT02793557
- Locations
- 🇩🇪
Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin, Berlin, Germany
News
No news found